Author： Vital Edward M
Publisher： Informa Healthcare
ISSN： 1471-2598
Source： Expert Opinion on Biological Therapy, Vol.13, Iss.7, 2013-09, pp. : 1049-1062
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Are biosimilars really generics?
By Misra Anoop
Expert Opinion on Biological Therapy, Vol. 10, Iss. 4, 2010-04 ,pp. :
Access to resources
Recommend
Biosimilars: current status and future directions
Expert Opinion on Biological Therapy, Vol. 10, Iss. 7, 2010-07 ,pp. :
Rituximab in hematopoietic cell transplantation
Expert Opinion on Biological Therapy, Vol. 10, Iss. 6, 2010-06 ,pp. :
Rituximab for chronic lymphocytic leukemia
Expert Opinion on Biological Therapy, Vol. 12, Iss. 4, 2012-04 ,pp. :